Table 3. Adverse events.
| Grade 1, n (%) | Grade 2, n (%) | Grade 3, n (%) | Grade 4, n (%) | |
|---|---|---|---|---|
| Anaemia |
10 (32) |
8 (26) |
7 (23) |
1 (3) |
| Neutropenia |
2 (6) |
3 (10) |
2 (6) |
0 |
| Leukopenia |
4 (13) |
8 (26) |
4 (13) |
3 (10) |
| Thrombocytopenia |
10 (32) |
12 (39) |
2 (6) |
0 |
| Fatigue |
13 (42) |
5 (16) |
7 (23) |
0 |
| Nausea |
15 (48) |
4 (13) |
4 (13) |
0 |
| Abdominal pain |
5 (16) |
1 (3) |
3 (10) |
0 |
| Diarrhoea |
7 (23) |
5 (16) |
2 (6) |
0 |
| Infection |
0 |
0 |
4 (13) |
0 |
| Neuropathy |
10 (32) |
5 (16) |
6 (19) |
0 |
| EGFR-related rash |
12 (39) |
6 (19) |
2 (6) |
0 |
| Elevated alkaline phosphatase |
12 (39) |
6 (19) |
2 (6) |
0 |
| Hypomagnesemia | 10 (32) | 9 (29) | 2 (6) | 0 |
Abbreviation: EGFR=epidermal growth factor receptor.